Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Shares Issued (2016 - 2025)

Historic Shares Issued for Abeona Therapeutics (ABEO) over the last 11 years, with Q2 2025 value amounting to $10.5 million.

  • Abeona Therapeutics' Shares Issued fell 8352.42% to $10.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$37.4 million, marking a year-over-year decrease of 14320.61%. This contributed to the annual value of $15.5 million for FY2024, which is 3266.18% down from last year.
  • As of Q2 2025, Abeona Therapeutics' Shares Issued stood at $10.5 million, which was down 8352.42% from $6.8 million recorded in Q1 2025.
  • Abeona Therapeutics' 5-year Shares Issued high stood at $63.7 million for Q2 2024, and its period low was -$54.7 million during Q4 2024.
  • In the last 5 years, Abeona Therapeutics' Shares Issued had a median value of $5.8 million in 2021 and averaged $7.1 million.
  • Per our database at Business Quant, Abeona Therapeutics' Shares Issued surged by 1750000.0% in 2021 and then tumbled by 546790000.0% in 2024.
  • Abeona Therapeutics' Shares Issued (Quarter) stood at $352000.0 in 2021, then skyrocketed by 7971.31% to $28.4 million in 2022, then plummeted by 100.0% to $1000.0 in 2023, then tumbled by 5467900.0% to -$54.7 million in 2024, then soared by 119.21% to $10.5 million in 2025.
  • Its Shares Issued stands at $10.5 million for Q2 2025, versus $6.8 million for Q1 2025 and -$54.7 million for Q4 2024.